Common Contracts
4 similar Joint Filing Agreement contracts by Cormorant Asset Management, LP
JOINT FILING AGREEMENTJoint Filing Agreement • December 28th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of December 28, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 6th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of July 6, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • June 26th, 2020 • Cormorant Asset Management, LP • Pharmaceutical preparations
This Joint Filing Agreement, dated as of June 26, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 24th, 2020 • Cormorant Asset Management, LP • Biological products, (no disgnostic substances)
This Joint Filing Agreement, dated as of February 24, 2020, is by and among Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP and Bihua Chen (collectively, the “Filers”).
